DYRK1A inhibitors (Translational Genomics Research Institute/ University of Arizona)

N/A

Report date: 2025/06/11 10:58:48
NME

Base Information

Drug NameDYRK1A inhibitors (Translational Genomics Research Institute/ University of Arizona)
Drug Alias Nameharmine (Translational Genomics Research Institute)beta carboline alkaloids (TGen)beta carboline alkaloids (Translational Genomics Research Institute)DYR-533DYR-219
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitorsMicrotubule-associated protein tau modulatorsNeuroprotectants +[4] 
TargetsMicrotubule-associated protein tauDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of ArizonaTranslational Genomics Research Institute
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A